Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Raw Materials (2022 - 2025)

Historic Raw Materials for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • Jin Medical International's Raw Materials rose 176.33% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 176.33%. This contributed to the annual value of $2.1 million for FY2025, which is 176.33% up from last year.
  • Jin Medical International's Raw Materials amounted to $2.1 million in Q3 2025, which was up 176.33% from $2.1 million recorded in Q3 2024.
  • In the past 5 years, Jin Medical International's Raw Materials ranged from a high of $3.3 million in Q3 2022 and a low of $2.1 million during Q3 2024
  • Over the past 4 years, Jin Medical International's median Raw Materials value was $2.4 million (recorded in 2023), while the average stood at $2.5 million.
  • Its Raw Materials has fluctuated over the past 5 years, first tumbled by 2130.66% in 2024, then surged by 176.33% in 2025.
  • Quarter analysis of 4 years shows Jin Medical International's Raw Materials stood at $3.3 million in 2022, then decreased by 20.04% to $2.6 million in 2023, then dropped by 21.31% to $2.1 million in 2024, then increased by 1.76% to $2.1 million in 2025.
  • Its Raw Materials stands at $2.1 million for Q3 2025, versus $2.1 million for Q3 2024 and $2.6 million for Q3 2023.